Evaluation of primary pulmonary carcinoid tumors using FDG PET.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9574618.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to determine the spectrum of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) findings in patients who have primary pulmonary carcinoid tumors. On FDG PET imaging, pulmonary carcinoid tumors usually have lower FDG uptake than expected for malignant tumors. Biopsy or close radiologic follow-up is therefore recommended for solitary pulmonary nodules that are clinically suspected of being carcinoid tumors and that do not show increased metabolic activity on FDG PET images.
Medical subject headings
- Carcinoid Tumor
- Fluorodeoxyglucose F18
- Lung Neoplasms
- Radiopharmaceuticals
- Tomography, Emission-Computed